| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/17/2008 | US20080090819 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-SULFONYLAMINO]-PROPIONAMIDE |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090790 Pharmaceutical composition comprising a corticosteroid and a specific inhibitor of hedgehog/smoothened signaling |
| 04/17/2008 | US20080090779 2-Benzyloxy-5-(2-bromoacetyl)-N-[3,5-bis(trifluoromethyl)phenyl-benzamide; diseases caused by production of immunoglobulin E: inflammatory cytokine, histamine, leukotriene and degranulation from activated mast cell; pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis, hysteromyoma |
| 04/17/2008 | US20080090772 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
| 04/17/2008 | US20080090769 topical cream containing sulfadiazine combined with 5 mu g of epidermal growth factor shows improvement |
| 04/17/2008 | US20080090757 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; 650 mu g/m2/day administered intravenously in cycles of 1-4 weeks; photosensitizing agent selected from methoxsalen, methotrexate, etretinate,corticosteroid, cyclosporine; nontoxic |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090751 Method of promoting healing of a tympanic membrane perforation |
| 04/17/2008 | US20080090290 Nucleic Acids Encoding Anti-IL-12 Antibodies, and Methods of Production |
| 04/17/2008 | US20080089958 Dermo-cosmetic compositions for topical and intravaginal application for treatment of human and veterinary affections caused by anaerobic organisms; vaginitis |
| 04/17/2008 | US20080089946 Synergistic Phytoceutical Compositions |
| 04/17/2008 | US20080089939 Dermastick thickened ointment |
| 04/17/2008 | US20080089915 Use of a specific inhibitor of hedgehog/smoothened signaling on hyperpigmented skin to obtain decrease of pigmentation |
| 04/17/2008 | US20080089906 Use of substances to protect FGF-2 or FGF-beta growth factor |
| 04/17/2008 | US20080089873 Method for Regenerating Hair Follicles by Suppressing a Gene with Hair Follicle Formation-Inhibiting Ability or by Activating a Gene with Hair Follicle Formation-Inducing Ability |
| 04/17/2008 | US20080089870 Cultured Melanocytes on Bioploymer Membranes for Treatment of Hyper and Hypopigmentation Disorders |
| 04/16/2008 | EP1911759A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911494A2 Use of oligosaccharides to stimulate beta-endorphin production |
| 04/16/2008 | EP1911358A1 New composition for improving skin quality and a process for preparing the same |
| 04/16/2008 | EP1910398A1 17-alpha-substituted derivatives of estradiol with wound-healing activity |
| 04/16/2008 | EP1910358A2 Heterocyclic janus kinase 3 inhibitors |
| 04/16/2008 | EP1910335A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 04/16/2008 | EP1909834A2 Use of hmgb1 antagonists for the treatment of inflammatory skin conditions |
| 04/16/2008 | EP1909821A2 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 04/16/2008 | EP1909802A2 Steroidal glycoside compounds as core 2 glcnac-t inhibitors |
| 04/16/2008 | EP1440059B1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | EP1169353B1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | CN101163681A Phthalazinone derivative and pharmaceutical comprising the same |
| 04/16/2008 | CN101163522A Method for increasing the speed of recovery and/or the speed of wound healing of injured animals |
| 04/16/2008 | CN101163492A Method of treating skin ulcers using oxidative reductive potential water solution |
| 04/16/2008 | CN101163491A Method of treating skin ulcers using oxidative reductive potential water solution |
| 04/16/2008 | CN101161688A Novel process for synthesizing povidone iodine by gas phase/ solid phase reaction |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161276A Nebula pressurized spray for treating rehabilitation of exogenous injury, empyrosis and bone fracture as well as its preparing method |
| 04/16/2008 | CN101161260A A medicine for treating beriberi |
| 04/16/2008 | CN101161259A A Chinese medicine lotion for preventing and controlling male and female pudendum disease |
| 04/16/2008 | CN101161255A A manufacturing method of Chinese medicine for treating scalding burn |
| 04/16/2008 | CN101161254A Ointment for treating acne |
| 04/16/2008 | CN101161228A Solid cosmetic and therapeutic compositions applicable to the human skin and gellable on contact with water |
| 04/16/2008 | CN100381462C Peptides and medicinal compositions containing the same |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381174C Preparation method of medicine for treating male baldness and its clinical application |
| 04/16/2008 | CN100381151C Dermatosis treating Chinese medicine prepn |
| 04/16/2008 | CN100381138C Chinese medicinal preparation for treating finger tip injury |
| 04/16/2008 | CN100381137C Wound repairing and burns treating cream |
| 04/16/2008 | CN100381124C Magnesium iso-glycyrrhetate gel and its preparing method and use |
| 04/16/2008 | CN100381123C Granules of clarityne and their production method |
| 04/16/2008 | CN100381120C Fibrauretine powder for injection and its production process |
| 04/15/2008 | US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358272 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating cancer, especially various types of leukemia |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/15/2008 | US7358243 1-[9-(3-Phenyl-allyl)-3,9 diaza-bicyclo[4.2.1]non-3-yl]-propan-1-one; analgesic; great selectivity to mu receptor; analgesic; pain relief, drug dependence, alcoholism; side effect reduction |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | CA2370201C Skin care compositions containing a combination of skin care actives |
| 04/15/2008 | CA2323239C Novel matrix metalloproteinase inhibitors and down-regulators |
| 04/15/2008 | CA2269655C Peptide compositions with growth factor-like activity |
| 04/10/2008 | WO2008043031A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/10/2008 | WO2008043019A1 8-substituted 2-(benzimidazolyl) purine derivatives for immunosuppression |
| 04/10/2008 | WO2008042197A1 Method of wound/burn healing using copper-zinc compositions |
| 04/10/2008 | WO2008041525A1 Furylmethylene malonamide compound and salt thereof, ultraviolet ray absorbent, and external preparation for skin |
| 04/10/2008 | WO2008041460A1 Active oxygen scavenger, activating agent and collagen production promoter each comprising cacalol |
| 04/10/2008 | WO2008041031A1 Wound healing compositions |
| 04/10/2008 | WO2008040967A1 Treatment of fibrosis |
| 04/10/2008 | WO2008040516A2 Microbiological composition and use thereof |
| 04/10/2008 | WO2008040230A1 Consolidant for trauma and ulcer comprising fibronectin |
| 04/10/2008 | WO2008040149A1 Composition and method for treating immune-mediated skin disorders |
| 04/10/2008 | WO2008015341A3 Use of a plant extract as active agent for increasing melanin synthesis in melanocytes |
| 04/10/2008 | WO2007149451B1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 04/10/2008 | WO2007135268A3 Use of peptides as active slimming ingredients |
| 04/10/2008 | WO2007105071A3 Composition for cosmetic or pharmaceutical-dermatological use |
| 04/10/2008 | WO2007048985A3 Substance for restoring normal co-expression and interaction between lox and nrage proteins |
| 04/10/2008 | US20080086000 Prostaglandin reductase |
| 04/10/2008 | US20080085939 Use Of Sphingolipids For Prevention And Treatment Of Atherosclerosis |
| 04/10/2008 | US20080085897 Inhibitors of cyclic guanosine monophosphate-metabolizing phosphodiesterases (cGMP PDE); cardiac insufficiency, cancer, bladder disorders, or prostate hyperplasia; 2-[2-ethoxy-5-(4-methyl-piperazine-1-sulphonyl)-phenyl]-5,7-dimethyl-3H-imidazo-[5,1-f]-[1,2,4]triazin-4-one for example |
| 04/10/2008 | US20080085890 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof |
| 04/10/2008 | US20080085876 Insect sting treatment |
| 04/10/2008 | US20080085873 Disease treatment methods |
| 04/10/2008 | US20080085861 Gas1 polypeptides |
| 04/10/2008 | US20080085858 Pharmaceutical Composition |
| 04/10/2008 | US20080085333 Antiinflammatory foods, cosmetics; antiacne; skin disorders |
| 04/10/2008 | US20080085328 Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof |
| 04/10/2008 | US20080085281 Using modulators of Dickkopf homolog 1 (DKK-1) activity as tool in treatment and prevention of osteolytic lesion; wnt signaling antagonist; antitumor agents |
| 04/10/2008 | US20080085245 with a detectable marker such as a food dye; presence of the anesthetic agent on the wound is indicated by the marker; anaesthetizing open wounds of animals, particularly those caused by husbandry procedures |
| 04/10/2008 | DE19541815B4 Verwendung einer Lösung von Polyethylenglykol in Wasser als wässrige Spüllösung zur Prävention oder Behandlung von zähem Schleim, der in Verbindung mit Strahlen- oder/und Chemotherapie-induzierten Erkrankungen der Schleimhäute auftritt Using a solution of polyethylene glycol in water as an aqueous rinse solution for the prevention or treatment of thick mucus that occurs in conjunction with radiotherapy and / or chemotherapy-induced disorders of the mucous membranes |
| 04/10/2008 | DE102006038471A1 Platanencreme, Verfahren zu ihrer Herstellung und Verwendung Plane cream, processes for their preparation and use |
| 04/09/2008 | EP1908779A1 Thymosin beta 4 derivatives and use thereof |
| 04/09/2008 | EP1908480A1 Interferon- alpha regulator |